Chugai Pharmaceutical Co. Ltd.

08/10/2022 | Press release | Distributed by Public on 08/10/2022 01:03

Anti-C5 Recycling Antibody Crovalimab Obtains Priority Review in China for the Treatment of Paroxysmal Nocturnal Hemoglobinuria